School of Pharmacy

Louis Garrison

Professor Emeritus, Department of Pharmacy; Assistant Director, Pharmaceutical Outcomes Research & Policy Program; Adjunct Professor and Co-Director of Global Medicines Program, UW Department of Global Health; Adjunct Professor, UW Department of Health Services

CHOICE Faculty, Department of Pharmacy, Pharmacy Faculty

Telephone: (206) 221-5684


Office Location: H-375-A Box 357630 1959 NE Pacific St Seattle, WA 98195-7630



  • PhD in Economics, Stanford University
  • Bachelor of Arts in Economics, Indiana University

Research Interests

  • National and international health policy issues
  • Economic evaluation of pharmaceuticals and diagnostics

Courses taught

  • PHARM 534/HSERV 583: Economic Evaluation in Health and Medicine
  • PHARM 568: Health Economics
  • PHARM 581: Global Health Pharmacy
  • PHARM 582C: Global Health Pharmacy-Pharmacoeconomics
  • PHARM 532: Pharmaceutical Policy


Dr. Garrison joined the School of Pharmacy faculty in 2004. For the first 13 years of his career, Dr. Garrison worked in non-profit health policy research first at the Battelle Human Affairs Research Centers (Seattle), and then at the Project HOPE Center for Health Affairs (Virginia), where he was the Director from 1989-1992.  Following this, he worked as an economist in the pharmaceutical industry for 12 years. From 2002-2004, he was Vice President and Head of Health Economics & Strategic Pricing in Roche Pharmaceuticals, based in Basel, Switzerland. In October 2016, he became Senior Visiting Fellow at the Office of Health Economics, London, UK.

Dr. Garrison received a BA in Economics from Indiana University, and a PhD in Economics from Stanford University. He has more than 125 publications in peer-reviewed journals.  He was elected as ISPOR President for July 2016-June 2017, and is serving on the Board for 2017-2018 as Immediate Past President, and as chair of the Council of Past Presidents.  He also recently co-chaired the ISPOR Special Task Force on U.S Value Frameworks, and is a member of the ISPOR Health Science Policy Council.

Dr. Garrison’s research interests include national and international health policy issues related to pharmacogenomics and personalized medicine, regulatory benefit-risk analysis, insurance, pricing, reimbursement and risk-sharing agreements, as well as the economic evaluation of pharmaceuticals, diagnostics, devices, surgical procedures, and vaccines, particularly as related to organ transplantation, renal disease, influenza, measles, obesity and cancer.